Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 5Neoplasms 4Chronic Pain 1Cancer Pain 1Breast Neoplasms 1Agnosia 1

Interventions

Bupivacaine 11Ketamine 9Ropivacaine 8Morphine 8Acetaminophen 8Fentanyl 7Dexmedetomidine 7Lidocaine 6Anesthesia, General 6Analgesics, Opioid 6Saline Solution 5Anesthesia, Local 5Acupuncture Therapy 5parecoxib 4Tramadol 4Sodium Chloride 4Pregabalin 4Ethanol 4Analgesia, Epidural 4Transcutaneous Electric Nerve Stimulation 3Radiofrequency Ablation 3Propofol 3Oxycodone 3Ketorolac 3Control Groups 3Anesthetics, Local 3trimebutine 3-thiocarbamoylbenzenesulfonate 2Therapeutics 2Surveys and Questionnaires 2Magnesium Sulfate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Agnosia × Tapentadol × Clear all
NCT01264887 2019-11-04

Tapentadol in Chronic Malignant Tumour Related Pain

Grünenthal GmbH

Phase 3 Terminated
31 enrolled 19 charts

Agnosia, Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡